Fair Value Measurements - Contingent Value Right and Common Stock Warrant Valuation (Detail) |
3 Months Ended | 6 Months Ended | |
|---|---|---|---|
|
Jun. 16, 2023
USD ($)
item
$ / shares
shares
|
Jun. 30, 2023
USD ($)
|
Jun. 30, 2023
USD ($)
|
|
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
| Change in valuation of contingent value right | $ (303,000) | $ (303,000) | |
| CVR Agreement | |||
| Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] | |||
| Number of components | item | 2 | ||
| Remaining value convertible | $ 3,000,000.0 | ||
| Expected value of conversion right if rights are not converted into shares | 0 | ||
| Fair value of conversion right | 3,300,000 | 2,900,000 | 2,900,000 |
| Fair value of contingent value liability | $ 1,900,000 | 1,900,000 | $ 1,900,000 |
| Change in valuation of contingent value right | $ 300,000 | ||
| Warrants to purchase shares of common stock | shares | 5,103,343 | ||
| Exercise price of warrant | $ / shares | $ 0.3919 | ||
| Warrants term | 10 years | ||
| Issuance of warrants | $ 2,300,000 |
| X | ||||||||||
- Definition Fair value portion of contingent value liability. No definition available.
|
| X | ||||||||||
- Definition Fair value of conversion right. No definition available.
|
| X | ||||||||||
- Definition Number of components of contingent value rights. No definition available.
|
| X | ||||||||||
- Definition Expected value of conversion right if rights are not converted into shares. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of contingent value rights. No definition available.
|
| X | ||||||||||
- Definition Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|